These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26144873)

  • 1. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
    Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population.
    Canesin G; Maggio V; Palominos M; Stiehm A; Contreras HR; Castellón EA; Morote J; Paciucci R; Maitland NJ; Bjartell A; Hellsten R
    Sci Rep; 2020 Aug; 10(1):13958. PubMed ID: 32811873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells.
    Don-Doncow N; Escobar Z; Johansson M; Kjellström S; Garcia V; Munoz E; Sterner O; Bjartell A; Hellsten R
    J Biol Chem; 2014 Jun; 289(23):15969-78. PubMed ID: 24755219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells.
    García V; Lara-Chica M; Cantarero I; Sterner O; Calzado MA; Muñoz E
    Oncotarget; 2016 Jan; 7(4):4490-506. PubMed ID: 26683224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASC-J9
    Lin W; Luo J; Sun Y; Lin C; Li G; Niu Y; Chang C
    Cancer Lett; 2018 Jul; 425():21-30. PubMed ID: 29425687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer.
    Sun SQ; Zhao YX; Li SY; Qiang JW; Ji YZ
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32784629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
    Hu M; Peng S; He Y; Qin M; Cong X; Xing Y; Liu M; Yi Z
    Oncotarget; 2015 Jun; 6(17):15348-61. PubMed ID: 25915156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supercritical Fluid Extraction of Citrus iyo Hort. ex Tanaka Pericarp Inhibits Growth and Induces Apoptosis Through Abrogation of STAT3 Regulated Gene Products in Human Prostate Cancer Xenograft Mouse Model.
    Kim C; Lee IH; Hyun HB; Kim JC; Gyawali R; Lee SG; Lee J; Kim SH; Shim BS; Cho SK; Ahn KS
    Integr Cancer Ther; 2017 Jun; 16(2):227-243. PubMed ID: 27185319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
    Zhang J; Ahn KS; Kim C; Shanmugam MK; Siveen KS; Arfuso F; Samym RP; Deivasigamanim A; Lim LH; Wang L; Goh BC; Kumar AP; Hui KM; Sethi G
    Antioxid Redox Signal; 2016 Apr; 24(11):575-89. PubMed ID: 26649526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.
    Handle F; Puhr M; Schaefer G; Lorito N; Hoefer J; Gruber M; Guggenberger F; Santer FR; Marques RB; van Weerden WM; Claessens F; Erb HHH; Culig Z
    Mol Cancer Ther; 2018 Dec; 17(12):2722-2731. PubMed ID: 30254184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors.
    Hellsten R; Lilljebjörn L; Johansson M; Leandersson K; Bjartell A
    Prostate; 2019 Oct; 79(14):1611-1621. PubMed ID: 31348843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.
    Hellsten R; Johansson M; Dahlman A; Sterner O; Bjartell A
    PLoS One; 2011; 6(7):e22118. PubMed ID: 21779382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma.
    Bao X; Ren T; Huang Y; Ren C; Yang K; Zhang H; Guo W
    Int J Oncol; 2017 Feb; 50(2):477-486. PubMed ID: 28000897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
    Lee JH; Kim C; Baek SH; Ko JH; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    Oncotarget; 2017 Mar; 8(11):17700-17711. PubMed ID: 27458171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
    Angelucci A; Gravina GL; Rucci N; Millimaggi D; Festuccia C; Muzi P; Teti A; Vicentini C; Bologna M
    Endocr Relat Cancer; 2006 Mar; 13(1):197-210. PubMed ID: 16601288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer.
    Ko H; Lee JH; Kim HS; Kim T; Han YT; Suh YG; Chun J; Kim YS; Ahn KS
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31058868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.
    Escobar Z; Bjartell A; Canesin G; Evans-Axelsson S; Sterner O; Hellsten R; Johansson MH
    J Med Chem; 2016 May; 59(10):4551-62. PubMed ID: 27111731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
    Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
    Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.